GPS Wealth Strategies Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
GPS Wealth Strategies Group's BMY Position: Q4 2025 in Review
GPS Wealth Strategies Group reduced its Bristol-Myers Squibb (BMY) stake by 73% in Q4 2025, selling an estimated $159K and leaving 1,200 shares worth $64.7K. The position accounts for 0.06% of the portfolio, ranked #192.
GPS Wealth Strategies Group first reported a position in BMY in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.11M in Q2 2022. 2,456 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- GPS Wealth Strategies Group held 1,200 shares of Bristol-Myers Squibb worth $64.7K as of Q4 2025.
- GPS Wealth Strategies Group sold 3,302 Bristol-Myers Squibb shares in Q4 2025, an estimated $159K.
- Bristol-Myers Squibb made up 0.06% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #192 holding.
- GPS Wealth Strategies Group first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 22 quarters since.
- GPS Wealth Strategies Group's Bristol-Myers Squibb position peaked at $1.11M in Q2 2022.
- 2,456 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.